Sep 29, 2024, 15:21
Joe Y Chang: Intensity-modulated proton vs photon therapy with concurrent chemo in medical inoperable stage III NSCLC
Joe Y Chang, Professor and Director, Stereotactic Ablative Radiotherapy Program, MD Anderson Cancer Center, shared a post on X:
“MD Anderson finished all enrollment of phase II randomized study comparing intensity-modulated proton vs photon therapy with concurrent chemo in medical inoperable stage III NSCLC.
I am lucky enough to enroll the last pt and received a nice bottle of wine from Zhongxing Liao.”
Source: Joe Y Chang/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 16, 2025, 22:19
Jan 16, 2025, 22:17
Jan 16, 2025, 17:18
Jan 16, 2025, 16:45
Jan 16, 2025, 16:28
Jan 16, 2025, 16:10
Jan 16, 2025, 16:03
Jan 16, 2025, 15:57
Jan 16, 2025, 15:50